Asset 1

Gentest® Hemoglobin (HbF) Induction Assay Service

Screen drugs to treat sickle cell disease and other Hemoglobinopathies.

Discovery’s HbF Induction Assay service screens drugs for their ability to increase levels of fetal hemoglobin (HbF), a high affinity oxygen transport protein that has been successful in easing serious hemoglobinopathy impacts.

Our service offers the ability to screen multiple compounds at once and allows for HbF induction comparison between test drugs and hydroxyurea (HU), the current, but suboptimal, standard of care for sickle cell disease (SCD) treatment.

Advanced, IND-Enabling Drug Screening for SCD and Hemoglobinopathies

Featured Resources

A Platform for Screening Drugs to Treat Sickle Cell Disease and Other Hemoglobinopathies

Whitepaper

Contact Us Today

Quick Links

Technologies

Development and Clinical
Trial Solutions